Skip to content

Collecting reference values for arterial stiffness and insulin resistance in healthy adolescents

Collecting reference values for arterial stiffness and insulin resistance in healthy adolescents - Stiffness of the Arteries and Insulin Resistance in healthy Adolescents

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37777
Enrollment
147
Registered
2012-05-10
Start date
2012-06-14
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis diabetes

Interventions

None listed

Sponsors

Sint Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Subjects age * 10 and -1.1 and

Exclusion criteria

Exclusion criteria: - Absence of a venous cannula for scheduled surgery. - Presence of T1DM or T2DM. - Hypertension defined as blood pressure >p95 for age, sex and height. - Use of corticosteroids, antihyperglycaemic drugs and/or antihypertensive drugs. ;To make sure that the measurements will not be influenced by renal insufficiency the glomerular filtration rate (GFR) will be measured. Also to make sure that the subjects will not have infections that influence the PWV, CRP will be measured. Subjects will be excluded if: - GFR 10 mg/l

Design outcomes

Primary

MeasureTime frame
The main study parameters of this study are: The reference values of the arterial stiffness, measured as PWV (ms-1) and the AIx (%) and insulin resistance, calculated as HOMA-IR of different Tanner stages in adolescents. These values will be expressed as mean, standard deviation and percentiles.

Secondary

MeasureTime frame
- Cardiovascular parameters: blood pressure, heart rate, lipid profile and renal function. - Demografic and anthropometric characteristics: sex, anthropometrics, bio-impedance, Tanner stage (I:1, II:2+3, III: 4+5). - Family history on diabetes mellitus, hypertension, cardiovascular disease, dislipidaemia and obesity. The family history will be reported as positive or negative and if positive, will be defined as first degree relatives (parents, siblings) and/or second degree relatives (grandparents). - Lifestyle: smoking, use of medicines, weekly exercise in hours, weekly amount of computer and television use in hours.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)